• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻已被用于治疗克罗恩病。

Cannabis finds its way into treatment of Crohn's disease.

作者信息

Schicho Rudolf, Storr Martin

机构信息

Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.

出版信息

Pharmacology. 2014;93(1-2):1-3. doi: 10.1159/000356512. Epub 2013 Dec 17.

DOI:10.1159/000356512
PMID:24356243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4076530/
Abstract

In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases. In a prospective placebo-controlled study, it has been shown what has been largely anticipated from anecdotal reports, i.e. that cannabis produces significant clinical benefits in patients with Crohn's disease. The mechanisms involved are not yet clear but most likely include peripheral actions on cannabinoid receptors 1 and 2, and may also include central actions.

摘要

在古代医学中,大麻就已被广泛用于治疗肠道紊乱和炎症。最近一项临床研究表明,药用植物大麻已不负众望,在治疗炎症性肠病方面被证明具有很高的疗效。在一项前瞻性安慰剂对照研究中,已证实了从轶事报道中大致预期的结果,即大麻对克罗恩病患者具有显著的临床益处。其中涉及的机制尚不清楚,但很可能包括对大麻素受体1和2的外周作用,也可能包括中枢作用。

相似文献

1
Cannabis finds its way into treatment of Crohn's disease.大麻已被用于治疗克罗恩病。
Pharmacology. 2014;93(1-2):1-3. doi: 10.1159/000356512. Epub 2013 Dec 17.
2
An overview of cannabis based treatment in Crohn's disease.大麻素治疗克罗恩病概述。
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):253-257. doi: 10.1080/17474124.2020.1740590. Epub 2020 Mar 12.
3
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.大麻可诱导克罗恩病患者产生临床应答:一项前瞻性安慰剂对照研究。
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
4
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?大麻素用于治疗炎症性肠病:我们目前的状况及未来走向?
Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):329-337. doi: 10.1080/17474124.2017.1292851. Epub 2017 Feb 16.
5
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.大麻素及其衍生物与炎症性肠病:超越滥用。
Int J Mol Sci. 2020 Apr 22;21(8):2940. doi: 10.3390/ijms21082940.
6
Cannabis for the treatment of Crohn's disease.大麻用于治疗克罗恩病。
Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012853. doi: 10.1002/14651858.CD012853.pub2.
7
Cannabis for inflammatory bowel disease.用于治疗炎症性肠病的大麻。
Dig Dis. 2014;32(4):468-74. doi: 10.1159/000358155. Epub 2014 Jun 23.
8
Cannabinoids for Inflammatory Bowel Disease: A Scoping Review.用于炎症性肠病的大麻素:一项范围综述。
Cannabis Cannabinoid Res. 2025 Feb;10(1):18-27. doi: 10.1089/can.2024.0061. Epub 2024 Jul 19.
9
The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation.大麻在对抗氧化应激和炎症方面的治疗潜力。
Molecules. 2021 Jul 28;26(15):4551. doi: 10.3390/molecules26154551.
10
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.低剂量大麻二酚在克罗恩病治疗中安全但无效:一项随机对照试验
Dig Dis Sci. 2017 Jun;62(6):1615-1620. doi: 10.1007/s10620-017-4540-z. Epub 2017 Mar 27.

引用本文的文献

1
Cannabidiol as an immune modulator: A comprehensive review.大麻二酚作为一种免疫调节剂:综述
Saudi Pharm J. 2025 May 23;33(3):11. doi: 10.1007/s44446-025-00005-7.
2
Management of Pelvic Pain in Patients with Crohn's Disease-Current Overview.克罗恩病患者盆腔疼痛的管理——当前概述
J Clin Med. 2023 Jan 9;12(2):526. doi: 10.3390/jcm12020526.
3
Complementary medicines used in ulcerative colitis and unintended interactions with cytochrome P450-dependent drug-metabolizing enzymes.用于溃疡性结肠炎的补充药物与细胞色素 P450 依赖性药物代谢酶的非预期相互作用。
Turk J Med Sci. 2022 Oct;52(5):1425-1447. doi: 10.55730/1300-0144.5482. Epub 2022 Oct 19.
4
Chronic delta-9-tetrahydrocannabinol (THC) treatment counteracts SIV-induced modulation of proinflammatory microRNA cargo in basal ganglia-derived extracellular vesicles.慢性 delta-9-四氢大麻酚 (THC) 处理可逆转 SIV 诱导的基底节衍生细胞外囊泡中促炎 microRNA 负荷的调节。
J Neuroinflammation. 2022 Sep 12;19(1):225. doi: 10.1186/s12974-022-02586-9.
5
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.内源性大麻素系统:治疗各种疾病的潜在靶点。
Int J Mol Sci. 2021 Aug 31;22(17):9472. doi: 10.3390/ijms22179472.
6
Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.内源性大麻素系统针对神经炎性自身免疫性疾病的治疗特性
Molecules. 2021 Jun 3;26(11):3389. doi: 10.3390/molecules26113389.
7
Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.炎症性肠病与大麻:临床医师实用指南。
Adv Ther. 2021 Jul;38(7):4152-4161. doi: 10.1007/s12325-021-01805-8. Epub 2021 Jun 10.
8
Cannabis for the treatment of ulcerative colitis.大麻用于治疗溃疡性结肠炎。
Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD012954. doi: 10.1002/14651858.CD012954.pub2.
9
Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis.肠 P 糖蛋白将内源性大麻素输出到细胞外以防止炎症和维持体内平衡。
J Clin Invest. 2018 Aug 31;128(9):4044-4056. doi: 10.1172/JCI96817. Epub 2018 Aug 13.
10
Acute inflammation: endogenous cannabinoids mellow the harsh proinflammatory environment.急性炎症:内源性大麻素使恶劣的促炎环境变得温和。
J Clin Invest. 2018 Aug 31;128(9):3750-3751. doi: 10.1172/JCI122885. Epub 2018 Aug 13.

本文引用的文献

1
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.大麻可诱导克罗恩病患者产生临床应答:一项前瞻性安慰剂对照研究。
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
2
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.炎症性肠病中的内源性大麻素系统:从病理生理学到治疗机会。
Trends Mol Med. 2012 Oct;18(10):615-25. doi: 10.1016/j.molmed.2012.07.009. Epub 2012 Aug 21.
3
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.大麻素受体 2 (CB2) 激动剂通过抑制 T 细胞的激活并促进其凋亡来改善 IL-10(-/-) 小鼠的结肠炎。
Toxicol Appl Pharmacol. 2012 Jan 15;258(2):256-67. doi: 10.1016/j.taap.2011.11.005. Epub 2011 Nov 18.
4
Treatment of Crohn's disease with cannabis: an observational study.大麻治疗克罗恩病:一项观察性研究。
Isr Med Assoc J. 2011 Aug;13(8):455-8.
5
Cannabis use amongst patients with inflammatory bowel disease.炎症性肠病患者的大麻使用情况。
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.
6
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.炎症性肠病患者肠道中的内源性大麻素系统。
Mucosal Immunol. 2011 Sep;4(5):574-83. doi: 10.1038/mi.2011.18. Epub 2011 Apr 6.
7
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice.萘-1-基-(4-戊氧基萘-1-基)甲酮(SAB378),一种外周受限的大麻素 CB1/CB2 受体激动剂,抑制胃肠动力,但对小鼠实验性结肠炎没有影响。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):973-80. doi: 10.1124/jpet.110.169946. Epub 2010 Jun 22.
8
Cannabinoids and the gut: new developments and emerging concepts.大麻素与肠道:新进展与新兴概念。
Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1.
9
Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.溃疡性结肠炎诱导人结肠组织中环烷烃系统表达的变化。
PLoS One. 2009 Sep 4;4(9):e6893. doi: 10.1371/journal.pone.0006893.
10
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.大麻素受体在人结肠中的差异表达:大麻素促进上皮伤口愈合。
Gastroenterology. 2005 Aug;129(2):437-53. doi: 10.1016/j.gastro.2005.05.026.